NuPathe, Inc. (PATH) Misses Q1 Loss Estimates
Tweet
Share
E-mailGet Alerts PATH Hot Sheet
Join SI Premium – FREE
NuPathe, Inc. (Nasdaq: PATH) reported Q1 loss of $0.56, $0.09 worse than the analyst estimate of ($0.47).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- AstraZeneca (AZN) Tops Q1 EPS by 110c; reaffirms guidance
- Teck Resources (TECK) Misses Q1 EPS by 15c; reaffirms FY guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
